Annual EBIT
-$528.62 M
+$105.15 M+16.59%
December 31, 2023
Summary
- As of February 7, 2025, NVAX annual earnings before interest & taxes is -$528.62 million, with the most recent change of +$105.15 million (+16.59%) on December 31, 2023.
- During the last 3 years, NVAX annual EBIT has fallen by -$125.50 million (-31.13%).
- NVAX annual EBIT is now -12147.80% below its all-time high of -$4.32 million, reached on December 31, 2005.
Performance
NVAX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$118.10 M
-$286.82 M-169.99%
September 30, 2024
Summary
- As of February 7, 2025, NVAX quarterly earnings before interest & taxes is -$118.10 million, with the most recent change of -$286.82 million (-169.99%) on September 30, 2024.
- Over the past year, NVAX quarterly EBIT has increased by +$10.52 million (+8.18%).
- NVAX quarterly EBIT is now -155.98% below its all-time high of $210.95 million, reached on March 31, 2022.
Performance
NVAX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$263.13 M
+$10.52 M+3.84%
September 30, 2024
Summary
- As of February 7, 2025, NVAX TTM earnings before interest & taxes is -$263.13 million, with the most recent change of +$10.52 million (+3.84%) on September 30, 2024.
- Over the past year, NVAX TTM EBIT has increased by +$272.81 million (+50.90%).
- NVAX TTM EBIT is now -28072.16% below its all-time high of -$934.00 thousand, reached on March 31, 2006.
Performance
NVAX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
NVAX EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +16.6% | +8.2% | +50.9% |
| 3 y3 years | -31.1% | +85.7% | +84.5% |
| 5 y5 years | -206.3% | -417.6% | -155.1% |
NVAX EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +68.8% | -156.0% | +85.7% | at high | +84.5% |
| 5 y | 5-year | -338.7% | +68.8% | -156.0% | +85.7% | -224.6% | +84.5% |
| alltime | all time | <-9999.0% | +68.8% | -156.0% | +85.7% | <-9999.0% | +84.5% |
Novavax EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$118.10 M(-170.0%) | -$263.13 M(-3.8%) |
| Jun 2024 | - | $168.73 M(-219.5%) | -$273.65 M(-28.2%) |
| Mar 2024 | - | -$141.18 M(-18.2%) | -$381.39 M(-27.9%) |
| Dec 2023 | -$528.62 M(-16.6%) | -$172.58 M(+34.2%) | -$528.62 M(-1.4%) |
| Sep 2023 | - | -$128.61 M(-310.9%) | -$535.94 M(-5.9%) |
| Jun 2023 | - | $60.99 M(-121.1%) | -$569.30 M(-49.8%) |
| Mar 2023 | - | -$288.41 M(+60.3%) | -$1.13 B(+78.8%) |
| Dec 2022 | -$633.77 M(-62.6%) | -$179.91 M(+11.1%) | -$633.77 M(-50.4%) |
| Sep 2022 | - | -$161.97 M(-67.8%) | -$1.28 B(-10.5%) |
| Jun 2022 | - | -$502.83 M(-338.4%) | -$1.43 B(+12.6%) |
| Mar 2022 | - | $210.95 M(-125.6%) | -$1.27 B(-25.2%) |
| Dec 2021 | -$1.69 B(+320.1%) | -$824.54 M(+164.9%) | -$1.69 B(+62.4%) |
| Sep 2021 | - | -$311.21 M(-9.2%) | -$1.04 B(+12.8%) |
| Jun 2021 | - | -$342.80 M(+59.3%) | -$924.55 M(+55.1%) |
| Mar 2021 | - | -$215.22 M(+23.9%) | -$596.23 M(+47.6%) |
| Dec 2020 | -$403.11 M(+234.5%) | -$173.69 M(-9.9%) | -$403.83 M(+56.0%) |
| Sep 2020 | - | -$192.85 M(+1232.4%) | -$258.92 M(+219.4%) |
| Jun 2020 | - | -$14.47 M(-36.6%) | -$81.07 M(-21.4%) |
| Mar 2020 | - | -$22.82 M(-20.7%) | -$103.15 M(-14.4%) |
| Dec 2019 | -$120.51 M(-30.2%) | -$28.78 M(+91.9%) | -$120.51 M(-12.7%) |
| Sep 2019 | - | -$15.00 M(-59.0%) | -$138.01 M(-16.1%) |
| Jun 2019 | - | -$36.56 M(-9.0%) | -$164.54 M(-2.9%) |
| Mar 2019 | - | -$40.17 M(-13.2%) | -$169.43 M(-1.8%) |
| Dec 2018 | -$172.56 M(+1.7%) | -$46.29 M(+11.5%) | -$172.56 M(-0.6%) |
| Sep 2018 | - | -$41.52 M(+0.2%) | -$173.59 M(+0.3%) |
| Jun 2018 | - | -$41.45 M(-4.3%) | -$173.16 M(+0.3%) |
| Mar 2018 | - | -$43.30 M(-8.5%) | -$172.66 M(+1.7%) |
| Dec 2017 | -$169.70 M(-36.4%) | -$47.32 M(+15.2%) | -$169.70 M(-3.6%) |
| Sep 2017 | - | -$41.09 M(+0.3%) | -$175.98 M(-11.0%) |
| Jun 2017 | - | -$40.95 M(+1.5%) | -$197.63 M(-15.0%) |
| Mar 2017 | - | -$40.34 M(-24.7%) | -$232.52 M(-12.9%) |
| Dec 2016 | -$267.00 M(+70.4%) | -$53.60 M(-14.6%) | -$267.00 M(-8.6%) |
| Sep 2016 | - | -$62.74 M(-17.3%) | -$292.10 M(+11.3%) |
| Jun 2016 | - | -$75.84 M(+1.4%) | -$262.41 M(+26.7%) |
| Mar 2016 | - | -$74.82 M(-4.9%) | -$207.18 M(+32.2%) |
| Dec 2015 | -$156.70 M(+89.3%) | -$78.69 M(+138.1%) | -$156.70 M(+43.0%) |
| Sep 2015 | - | -$33.06 M(+60.3%) | -$109.54 M(+13.9%) |
| Jun 2015 | - | -$20.61 M(-15.3%) | -$96.17 M(+3.0%) |
| Mar 2015 | - | -$24.33 M(-22.8%) | -$93.37 M(+12.8%) |
| Dec 2014 | -$82.79 M(+59.8%) | -$31.54 M(+60.3%) | -$82.79 M(+26.8%) |
| Sep 2014 | - | -$19.68 M(+10.5%) | -$65.27 M(+7.3%) |
| Jun 2014 | - | -$17.81 M(+29.5%) | -$60.83 M(+9.4%) |
| Mar 2014 | - | -$13.76 M(-1.9%) | -$55.60 M(+7.3%) |
| Dec 2013 | -$51.80 M(+81.9%) | -$14.02 M(-8.0%) | -$51.80 M(+13.1%) |
| Sep 2013 | - | -$15.24 M(+21.1%) | -$45.79 M(+21.2%) |
| Jun 2013 | - | -$12.58 M(+26.4%) | -$37.77 M(+21.4%) |
| Mar 2013 | - | -$9.96 M(+24.2%) | -$31.10 M(+9.2%) |
| Dec 2012 | -$28.48 M(+50.3%) | -$8.02 M(+11.1%) | -$28.48 M(+17.8%) |
| Sep 2012 | - | -$7.21 M(+21.9%) | -$24.16 M(+19.8%) |
| Jun 2012 | - | -$5.92 M(-19.3%) | -$20.16 M(+7.1%) |
| Mar 2012 | - | -$7.33 M(+98.1%) | -$18.82 M(-0.6%) |
| Dec 2011 | -$18.94 M(-47.6%) | -$3.70 M(+15.3%) | -$18.94 M(-13.3%) |
| Sep 2011 | - | -$3.21 M(-29.9%) | -$21.84 M(-24.7%) |
| Jun 2011 | - | -$4.58 M(-38.5%) | -$28.98 M(-12.9%) |
| Mar 2011 | - | -$7.45 M(+13.0%) | -$33.26 M(-10.7%) |
| Dec 2010 | -$36.15 M | -$6.60 M(-36.3%) | -$37.26 M(-20.7%) |
| Sep 2010 | - | -$10.36 M(+17.0%) | -$47.00 M(+4.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2010 | - | -$8.86 M(-22.7%) | -$44.90 M(+2.3%) |
| Mar 2010 | - | -$11.45 M(-29.9%) | -$43.88 M(+10.9%) |
| Dec 2009 | -$39.56 M(+15.1%) | -$16.33 M(+97.7%) | -$39.56 M(+22.0%) |
| Sep 2009 | - | -$8.26 M(+5.5%) | -$32.44 M(-4.3%) |
| Jun 2009 | - | -$7.83 M(+9.7%) | -$33.90 M(-1.1%) |
| Mar 2009 | - | -$7.14 M(-22.5%) | -$34.28 M(-0.2%) |
| Dec 2008 | -$34.36 M(+13.5%) | -$9.21 M(-5.3%) | -$34.36 M(+20.8%) |
| Sep 2008 | - | -$9.73 M(+18.6%) | -$28.45 M(+1.7%) |
| Jun 2008 | - | -$8.20 M(+13.6%) | -$27.98 M(-1.8%) |
| Mar 2008 | - | -$7.22 M(+119.1%) | -$28.50 M(-2.1%) |
| Dec 2007 | -$30.27 M(+43.4%) | -$3.30 M(-64.4%) | -$29.12 M(-0.2%) |
| Sep 2007 | - | -$9.26 M(+6.1%) | -$29.17 M(+13.9%) |
| Jun 2007 | - | -$8.72 M(+11.3%) | -$25.61 M(+7.1%) |
| Mar 2007 | - | -$7.84 M(+134.1%) | -$23.92 M(+13.3%) |
| Dec 2006 | -$21.12 M(+389.2%) | -$3.35 M(-41.2%) | -$21.12 M(+240.4%) |
| Sep 2006 | - | -$5.69 M(-19.1%) | -$6.20 M(+125.8%) |
| Jun 2006 | - | -$7.04 M(+39.8%) | -$2.75 M(+194.1%) |
| Mar 2006 | - | -$5.04 M(-143.5%) | -$934.00 K(-78.4%) |
| Dec 2005 | -$4.32 M(-82.4%) | $11.56 M(-616.9%) | -$4.32 M(-83.3%) |
| Sep 2005 | - | -$2.24 M(-57.2%) | -$25.79 M(-0.3%) |
| Jun 2005 | - | -$5.22 M(-37.9%) | -$25.87 M(-7.6%) |
| Mar 2005 | - | -$8.42 M(-15.0%) | -$27.98 M(+14.4%) |
| Dec 2004 | -$24.46 M(+52.4%) | -$9.91 M(+327.1%) | -$24.46 M(+38.9%) |
| Sep 2004 | - | -$2.32 M(-68.4%) | -$17.62 M(-3.5%) |
| Jun 2004 | - | -$7.34 M(+49.9%) | -$18.26 M(+17.4%) |
| Mar 2004 | - | -$4.90 M(+60.0%) | -$15.55 M(-3.1%) |
| Dec 2003 | -$16.05 M(-25.5%) | -$3.06 M(+3.4%) | -$16.05 M(-6.0%) |
| Sep 2003 | - | -$2.96 M(-36.1%) | -$17.09 M(-17.1%) |
| Jun 2003 | - | -$4.63 M(-14.2%) | -$20.60 M(-4.1%) |
| Mar 2003 | - | -$5.40 M(+32.0%) | -$21.49 M(-0.3%) |
| Dec 2002 | -$21.56 M(+132.9%) | -$4.09 M(-36.8%) | -$21.56 M(+5.1%) |
| Sep 2002 | - | -$6.48 M(+17.5%) | -$20.52 M(+25.0%) |
| Jun 2002 | - | -$5.51 M(+0.7%) | -$16.41 M(+30.5%) |
| Mar 2002 | - | -$5.47 M(+79.6%) | -$12.58 M(+35.9%) |
| Dec 2001 | -$9.26 M(-27.4%) | -$3.05 M(+28.5%) | -$9.26 M(-18.0%) |
| Sep 2001 | - | -$2.37 M(+41.0%) | -$11.29 M(-8.2%) |
| Jun 2001 | - | -$1.68 M(-21.9%) | -$12.29 M(-8.5%) |
| Mar 2001 | - | -$2.15 M(-57.7%) | -$13.44 M(+5.5%) |
| Dec 2000 | -$12.74 M(+177.0%) | -$5.08 M(+50.6%) | -$12.74 M(+45.5%) |
| Sep 2000 | - | -$3.38 M(+19.4%) | -$8.76 M(+21.9%) |
| Jun 2000 | - | -$2.83 M(+94.3%) | -$7.18 M(+39.3%) |
| Mar 2000 | - | -$1.46 M(+32.3%) | -$5.16 M(+12.1%) |
| Dec 1999 | -$4.60 M(-11.5%) | -$1.10 M(-38.9%) | -$4.60 M(-11.5%) |
| Sep 1999 | - | -$1.80 M(+125.0%) | -$5.20 M(+10.6%) |
| Jun 1999 | - | -$800.00 K(-11.1%) | -$4.70 M(-9.6%) |
| Mar 1999 | - | -$900.00 K(-47.1%) | -$5.20 M(0.0%) |
| Dec 1998 | -$5.20 M(+8.3%) | -$1.70 M(+30.8%) | -$5.20 M(+13.0%) |
| Sep 1998 | - | -$1.30 M(0.0%) | -$4.60 M(+2.2%) |
| Jun 1998 | - | -$1.30 M(+44.4%) | -$4.50 M(0.0%) |
| Mar 1998 | - | -$900.00 K(-18.2%) | -$4.50 M(-4.3%) |
| Dec 1997 | -$4.80 M(-12.7%) | -$1.10 M(-8.3%) | -$4.70 M(-13.0%) |
| Sep 1997 | - | -$1.20 M(-7.7%) | -$5.40 M(+3.8%) |
| Jun 1997 | - | -$1.30 M(+18.2%) | -$5.20 M(0.0%) |
| Mar 1997 | - | -$1.10 M(-38.9%) | -$5.20 M(0.0%) |
| Dec 1996 | -$5.50 M | -$1.80 M(+80.0%) | -$5.20 M(+52.9%) |
| Sep 1996 | - | -$1.00 M(-23.1%) | -$3.40 M(+41.7%) |
| Jun 1996 | - | -$1.30 M(+18.2%) | -$2.40 M(+118.2%) |
| Mar 1996 | - | -$1.10 M | -$1.10 M |
FAQ
- What is Novavax annual earnings before interest & taxes?
- What is the all time high annual EBIT for Novavax?
- What is Novavax annual EBIT year-on-year change?
- What is Novavax quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Novavax?
- What is Novavax quarterly EBIT year-on-year change?
- What is Novavax TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Novavax?
- What is Novavax TTM EBIT year-on-year change?
What is Novavax annual earnings before interest & taxes?
The current annual EBIT of NVAX is -$528.62 M
What is the all time high annual EBIT for Novavax?
Novavax all-time high annual earnings before interest & taxes is -$4.32 M
What is Novavax annual EBIT year-on-year change?
Over the past year, NVAX annual earnings before interest & taxes has changed by +$105.15 M (+16.59%)
What is Novavax quarterly earnings before interest & taxes?
The current quarterly EBIT of NVAX is -$118.10 M
What is the all time high quarterly EBIT for Novavax?
Novavax all-time high quarterly earnings before interest & taxes is $210.95 M
What is Novavax quarterly EBIT year-on-year change?
Over the past year, NVAX quarterly earnings before interest & taxes has changed by +$10.52 M (+8.18%)
What is Novavax TTM earnings before interest & taxes?
The current TTM EBIT of NVAX is -$263.13 M
What is the all time high TTM EBIT for Novavax?
Novavax all-time high TTM earnings before interest & taxes is -$934.00 K
What is Novavax TTM EBIT year-on-year change?
Over the past year, NVAX TTM earnings before interest & taxes has changed by +$272.81 M (+50.90%)